Study of Subcutaneous and Intravenous Velcade in Combination With Dexamethasone in Chinese Subjects With Relapsed and Refractory Multiple Myeloma

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
The purpose of this phase 3 study is to determine if subcutaneous velcade is non-inferior to intravenous velcade when administered in combination with low-dose dexamethasone in chinese refractory or relapsed multiple myeloma (r/rMM) patients. The study will assess the overall response rate after 4 cycles of velcade and dexamethasone administration.
Epistemonikos ID: d0f9d2b827dcfa486e0d48f6c44ba02af8102f4f
First added on: May 17, 2024